Daniel Glenn Stout, MD | |
2390 W Congress St, Lafayette, LA 70506-4205 | |
(337) 261-6480 | |
Not Available |
Full Name | Daniel Glenn Stout |
---|---|
Gender | Male |
Speciality | Endocrinology |
Experience | 18 Years |
Location | 2390 W Congress St, Lafayette, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821288119 | NPI | - | NPPES |
1-50065-8 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MD.201440 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Hospital & Clinics | Lafayette, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lsuhn Billing Llc | 0446337802 | 194 |
News Archive
As many as one in 90 children are today being diagnosed with autism-and autism research continues to focus almost exclusively on genetics. In its January/February 2010 issue (posted now at: www.emagazine.com), E-The Environmental Magazine looks at another factor that may be driving up autism rates-environmental toxicity.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4>th EAACI Congress in London on June 7th. The results will be presented by the study's principal investigator Prof. Eric Bateman.
NeurogesX, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza(TM) (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia (PHN), the nerve pain which can follow shingles.
(Garrison, NY) The latest issue of the Hastings Center Report features articles on "medicalized" weapons that temporarily incapacitate targets, sharing the benefits of newly found biological resources, and applications of GINA (the Genetic Information Nondisclosure Act).
› Verified 6 days ago
Entity Name | Lsuhn Billing Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992975775 PECOS PAC ID: 0446337802 Enrollment ID: O20080409000372 |
News Archive
As many as one in 90 children are today being diagnosed with autism-and autism research continues to focus almost exclusively on genetics. In its January/February 2010 issue (posted now at: www.emagazine.com), E-The Environmental Magazine looks at another factor that may be driving up autism rates-environmental toxicity.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4>th EAACI Congress in London on June 7th. The results will be presented by the study's principal investigator Prof. Eric Bateman.
NeurogesX, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza(TM) (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia (PHN), the nerve pain which can follow shingles.
(Garrison, NY) The latest issue of the Hastings Center Report features articles on "medicalized" weapons that temporarily incapacitate targets, sharing the benefits of newly found biological resources, and applications of GINA (the Genetic Information Nondisclosure Act).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Daniel Glenn Stout, MD 2390 W Congress St, Lafayette, LA 70506-4205 Ph: () - | Daniel Glenn Stout, MD 2390 W Congress St, Lafayette, LA 70506-4205 Ph: (337) 261-6480 |
News Archive
As many as one in 90 children are today being diagnosed with autism-and autism research continues to focus almost exclusively on genetics. In its January/February 2010 issue (posted now at: www.emagazine.com), E-The Environmental Magazine looks at another factor that may be driving up autism rates-environmental toxicity.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4>th EAACI Congress in London on June 7th. The results will be presented by the study's principal investigator Prof. Eric Bateman.
NeurogesX, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza(TM) (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia (PHN), the nerve pain which can follow shingles.
(Garrison, NY) The latest issue of the Hastings Center Report features articles on "medicalized" weapons that temporarily incapacitate targets, sharing the benefits of newly found biological resources, and applications of GINA (the Genetic Information Nondisclosure Act).
› Verified 6 days ago
Dr. Maximo Bienvenido Lamarche, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 300 W Saint Mary Blvd, Lafayette, LA 70506 Phone: 337-233-6593 Fax: 337-235-1032 | |
Dr. John M Rainey, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 501 W Saint Mary Blvd, Lafayette, LA 70506 Phone: 337-235-7898 Fax: 337-235-7445 | |
Dr. Corwin Ashford Thomas, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 802 E Farrel Rd, Lafayette, LA 70508 Phone: 337-234-3163 Fax: 337-234-3168 | |
Dr. Matthew Shane Fontenot, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1214 Coolidge Blvd, Lafayette, LA 70503 Phone: 337-289-7927 Fax: 337-289-7935 | |
Dr. John Brent Rhodes Jr., M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 439 Heymann Blvd, Lafayette, LA 70503 Phone: 337-269-0963 Fax: 337-269-0553 | |
Leela P. Lakshmiprasad, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: Lsu Medicine Clinic, 2390 W Congress Street, Lafayette, LA 70506 Phone: 337-261-6100 | |
Dr. Kamalendra Nath Mondal, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3149 Ambassador Caffery Pkwy, Lafayette, LA 70506 Phone: 337-706-3415 |